0  

Shape the Future of Senior Living Management

Seniors flipping through memories in a photo album

Driven by longer lifespans and the aging Baby Boomer generation, the number of older adults in the United States is expected to exceed 80 million by 2040, accelerating the demand for senior living solutions. Professionals in the sector are adapting to provide affordable housing and quality care as demographics shift.

Heather Kolakowski, interim executive director for the Cornell Institute for Healthy Futures, and seasoned industry specialists discussed potential solutions for creating sustainable and inclusive senior living environments in a recent Keynote webcast, “Affordable Senior Living: Challenges and Opportunities Ahead.”

Subsidized or Affordable: What’s the Difference?

Rent-to-income ratios are a key indicator of housing affordability. Financial experts frequently advise families to spend below 30 percent of their income on rent, and those who spend more are deemed cost-burdened.

“We are currently in the midst of an affordable housing crisis, and you probably wouldn’t know that from looking at the housing prices these days,” said Severine Petras, CEO and co-founder of Priority Life Care. “Nearly one in three households devotes more than 30 percent of their income to their mortgages.”

Subsidized and affordable housing are two distinct yet related concepts. Subsidized housing, often supported by the Department of Housing and Urban Development through programs like Section 8, ensures individuals do not pay more than 30 percent of their income toward housing. Affordable housing refers to units that are offered below market rates without government support.

Rising Costs on All Fronts

With rent prices increasing faster than income growth, seniors will have difficulty finding affordable housing options in the future. Jay Woolford, senior vice president at CIRC, questions how providers will meet the growing needs: “As rents go up and the cost of housing continues to go up, how do we fill the gap for people? How do we begin to look at ways to manage housing costs and be able to provide them opportunities for nutrition, for transportation, for healthcare, for access to entertainment?”

Financing senior living facilities is another hindrance, with tax credit investors, opportunity zone funds, and volume cap bonds playing crucial roles. Woolford has explored alternative financing with his own Tukwila Village project, a mixed-used senior housing development project in Washington state.

“We were getting tax credit investors to put in the bulk of the equity for the project. We actually used opportunity zone funds as the final equity piece of that,” said Woolford. “But the struggle now is the availability of volume cap bonds. The demand is outstripping the capacity.”

Senior living management professionals also face rising labor costs and a reliance on government subsidies. With labor being the most significant expense for assisted living facilities, providers must find ways to balance the need for qualified staff with the rising costs of care.

“The bigger problem is operationally making sure that you’re able to meet the extreme demands on an expense side,” said Petras. “When you’re talking about the revenue, we’re talking about relying on a government subsidy.”

Creative Strategies for a Brighter Future

The community aspect of senior living alleviates the heftier burden of healthcare service costs seniors and their families would otherwise face with private care. Maintaining this important benefit for aging adults requires innovative solutions.

Tukwila Village demonstrates how cities can provide land to facilitate the development of affordable housing communities. “The property was actually owned by the city of Tukwila. They had aggregated a little under six acres. And we worked with the city to be able to put this together in order to do affordable senior housing on the property in conjunction with a number of other partners,” said Woolford.

Modular housing, which involves the assembly of prefabricated housing units, can offer a faster and more cost-effective approach to building senior living facilities.

“Manufactured housing has a dirty reputation, especially after a hurricane. But the reality is that new manufactured homes are actually built better today,” said Mitch Brown, principal consultant for Senior Housing Consulting. “The new regulations for building those communities are more rigorous in terms of tie downs and everything that has to happen.”

Cornell’s Senior Living Management certificate program introduces professionals to best practices for service excellence at senior living facilities. Learn more and enroll today.

Watch the full “Affordable Senior Living: Challenges and Opportunities Ahead” Keynote on the eCornell website.

  0  

What is Your Style of Decision-Making? Strategize for Influence.

Imagine unlocking the secret to success in both business and day-to-day life. It’s all rooted in one critical talent: strategic decision-making – the essence of exceptional leadership, the engine driving meaningful change, and the spark igniting innovation.

Cheryl Strauss Einhorn, adjunct professor in Cornell’s SC Johnson College of Business, is a pioneer in shaping our understanding of this crucial skill. She is an accomplished author, educator, the creator of the AREA Method – a game-changing problem-solving approach – and the author of the Complex Decision-Making Cornell certificate program.

Her insights have reshaped how leaders steer their decision-making strategies and offer valuable lessons for navigating the complexity of the corporate world and your career.

Einhorn shared some key decision-making guidelines in a recent Keynotes webcast hosted by eCornell:

Understanding Strategic Choices

Einhorn believes that our problem-solving styles are behaviors with which we feel most adept and comfortable. She asserts, “we all have a comfort, a dominant problem solver profile. And we can all become more dynamic problem solvers.” This perspective champions the inherent adaptability within each of us to navigate different problem-solving styles.

The Adaptability of Problem-Solving Styles

Contrary to popular belief, problem-solving styles aren’t prescriptive. Instead, they offer space for adaptability and growth. Acknowledging our problem-solving styles provides a valuable opportunity for self-awareness and interpersonal development.

Einhorn defines five distinct styles of decision making that offer unique perspectives into the world of strategic problem solving:

The Adventurer: Einhorn describes the adventurer as “a very decisive decision maker. She knows what she wants. The future is endlessly more interesting than the present.”

The Detective: With a strong need for concrete evidence, the detective is “a slower decision maker because she wants to find data.”

The Listener: This style of decision maker is “relational, collaborative, trusting,” Eihorn said. “She emphasizes the importance of gathering input, and she likes to gather the wisdom and opinions of others.”

The Thinker: Someone who “values understanding the why and thinking about the different options.” This style represents a “thoughtful, careful decision maker.”

The Visionary: “A big, creative, out-of-the-box thinker.” Einhorn warns, however, that “this kind of decision maker could have a planning fallacy.” Visionaries can dream big and are often the source of innovative ideas, but they must stay grounded to avoid unrealistic expectations.

Decision-making styles are dynamic, changeable over time, and influenced by various factors such as age, experiences, and environments. For example, your style at work might differ from your style at home. Einhorn explains that you have the freedom to choose your problem-solving style based on the situation: “You could decide that you want to plan a meal as a visionary. You want to take a vacation as an adventurer. You want to buy insurance as a detective. And each of these opportunities are available to you once you understand the five different profiles.”

No “Perfect” Combination

Harnessing the power of strategic decision makers isn’t about achieving a “perfect” combination of problem-solving styles. The real value lies in understanding and leveraging diverse profiles to become more effective leaders.

Awareness of these profiles can offer insights into the kind of information each leader needs and highlight any cognitive biases that might obstruct effective problem solving. “You can learn what this means that you’re good at and the places where each of us might have mental mistakes that are most relevant to getting in our way. And then how we can make better choices together,” Einhorn said.

With this knowledge, we can fill gaps in perspective, ensure a more comprehensive understanding of situations, and contribute more effectively to collective problem-solving processes to foster strategic leadership and decision making.

In mastering the craft of strategic leadership, we pave our own route toward personal and professional achievement. Adopt an introspective approach and learn to leverage your unique problem-solving styles in Cornell’s Complex Decision-Making certificate program. You’ll gain a dynamic skill set to boost your confidence, empower your choices, and drive significant change in all aspects of your life.

Watch Einhorn’s Making Difficult Decisions Keynote webcast on the eCornell website.

  0  

Bringing New Science to Market

Medical supplies and drugs, including a syringe, surgical mask, and pills

Medical innovation is reaching new heights every year. What scientific breakthroughs can we expect on the market in the coming decade? What challenges will we face in adopting them?

Professor Sean Nicholson, director of the Cornell Sloan Program in Health Administration, welcomed Wyatt Gotbetter, SVP and worldwide head of Parexel Access Consulting, and Dr. Gregory B. Franz, MD, MPH, MHA, hematologist and medical oncologist at the Kirkland Cancer Center, to explore answers to these questions in the recent Keynote webcast “Bringing New Science to Market: Innovation, Adoption, and Health Policy Challenges.”

Biotech and pharmaceutical firms spend about $80 billion each year on research and development in order to try to bring new therapies to the market. What is in the pipeline that might have a big positive effect on the health of the population in the future?

Gotbetter: “If we think just about the past five years, and of course that includes the pandemic, I think the rate of innovation and the number of launches has been remarkable. We can’t have this discussion without acknowledging the validation and the importance to all of us of the RNAi vaccines from BioNTech and Moderna. Moderna, on the heels of that success and being flush with sales of their COVID vaccine, is really advancing a number of therapeutic products as well as vaccines – really advancing their RNAi technology into the therapeutic space and oncology specifically.

In the same time, we’ve seen the approval of a couple of CAR-Ts truly advancing life-saving therapy in hematology and oncology. I think we’ll see gene therapies becoming safer and easier to manufacture, hopefully at lower costs. There’s just a pipeline of literally hundreds of programs where we’ll see gene therapy go from rare disease and disease that has very, very high morbidity perhaps into things managed more chronically with small molecule drugs – like heart failure.”

We have a couple of CAR-T therapies on the market that are Food and Drug Administration (FDA) approved. Are there similar kinds of classes of compounds that have yet to be approved that you think might potentially have a similar health impact?

Franz: “Leveraging the immune system to identify and kill cancer cells – that’s really what’s going on here. This is T cells doing what T cells do against cancer cells. I know that’s a very simple explanation. It’s very difficult to develop these compounds and to do this safely, but I think that’s where the money and the future is.”

It takes a long time, and it’s very expensive for biotech and pharmaceutical firms to run clinical trials and, even preceding that, to identify compounds that are promising enough to start a clinical trial. The current estimate is about $2.6 billion in investment across a portfolio of compounds in order to statistically assure a company that they’re going to have one approved compound. Where do companies come up with that money, and in the current climate, is it difficult for companies to raise the funds they need in order to invest in those drugs?

Gotbetter: “That $2.6 billion figure also includes the cost of failure. Even if we think about a successful drug compound, if you boil down the numbers, hundreds and hundreds of drug candidates will be considered before you start your phase one and then roughly one in ten of those will make it through to approval. It’s fraught with risk. But even if you could streamline that process, you’re probably looking at hundreds of millions to a billion dollars.

The amount of money that’s poured into the biotech sector over the past few years has been remarkable. We’ve seen, though, a massive sea change in the past year. Biotech has been the engine of discovery and innovation for large pharmaceutical companies. The largest companies in the world that certainly have formidable R&D engines employing thousands of people still turn to biotech to find innovation, to find a compound that has been tested, that shows a proof of concept, and can move forward.

The headwinds of the past year or two – interest rates and some of the perceived threats of the Inflation Reduction Act, which could reduce pricing power of the industry – has really slowed down [venture capital] funding.

I think what that means is that probably the rate of innovation will slow down a little bit in the sense that there may be fewer programs being pursued simultaneously, so a company may really focus on the crown jewels instead of many at once. Then biotech may again have to be more reliant on Big Pharma once they’re in the middle of their development versus a period where they probably could see funding to go all the way through.”

What are the factors that make a drug widely adopted?

Franz: “In the medical oncology world, it’s really all about safety and efficacy. Is the drug difficult to give? Does the patient have a lot of adverse side effects? How do you manage those side effects? But most importantly, you’re looking at endpoints: PFS, or progression-free survival, and OS, or overall survival. Duration of response and response rate are biggies and, of course, the toxicity profile. All those together are important. The better the PFS and OS, the more successful the drug is going to be.”

Are biotech and pharmaceutical firms doing anything to try to run their trials differently – to be less expensive, to be shorter, to have higher probability of approval?

Gotbetter: “The FDA provides a rubric that says for very life-threatening diseases, it will work with the industry sponsor to find a way to streamline the therapy. We have names for that in the U.S like breakthrough therapies and accelerated pathways, where you get more support and guidance from the regulatory agency, but you’re also partnering with them along the way to find a way to expedite the study.

There’s a lot of companies that are using all sorts of AI, computational methods and synthetic biology to [speed up the trial process].”

Historically, clinical trials have been dominated by white men. Are biotech and pharmaceutical firms trying to diversify those trials? What are the implications potentially of a more representative group of patients in the testing phase?

Gotbetter: “There are mandates coming from the FDA and other governments, and I think very sincere efforts from the pharma industry and from clinical research organizations who enroll and operationalize the studies to really bring diversity into studies. There’s an awareness in society for many reasons, for many historical wrongs, we need to bring more diversity into everything we do. It’s to really ensure that when we study a drug, we’ll be able to show efficacy in different populations because we’re not all the same. Historically, if you were to develop a drug for people of European descent, across the globe in Asian markets, they would want to know that there was a study being done in populations for which the results were meaningful for them. As we take that to other populations, to different age groups, different genders, it’s the right thing to do.”

 

This post has been edited for length and clarity.

Want to learn more about the future of biopharma? Register for Cornell’s Biotech and Pharmaceutical Management Immersion Program and watch the full Keynote “Bringing New Science to Market” webcast online.

  0  

Cornell debuts biotech, pharma management program

Networking at Cornell Tech

As biotechnology and pharmaceutical professionals continue efforts to make advances in medicinal drug formulation, safety and efficacy, experts in the field are implementing innovations to address regulatory hurdles, research costs and global health challenges.

The new Biotech and Pharmaceutical Management Program offered through the Cornell Jeb E. Brooks School of Public Policy is designed to give leaders the opportunity to explore industry trends and cutting edge research with a cohort of peers, executives and renowned faculty from the university.

Read the full story on the Cornell Chronicle.

  0  

Cornell Brooks EMHA ranked in top 10 health care management grad programs

The Cornell Jeb E. Brooks School of Public Policy Executive Master of Health Administration (EMHA) is one of the top 10 executive health care management graduate programs in the nation, according to rankings published by Modern Healthcare Magazine.

Of 25 programs, the Cornell Brooks EMHA ranked No. 9 based on alumni survey data from the Commission on Accreditation of Healthcare Management Education (CAHME). The commission calculated each institution’s Net Promoter Score, which measures the likelihood that graduates would positively recommend a program. CAHME published the average scores for the 2020-21 and 2021-22 academic years and Cornell’s EMHA received a score demonstrating high satisfaction – 81 out of 100.

Read the full story on the Cornell Chronicle website.

  0  

Center for Virtual Care expands digital health training

Digital health and the tools for patients to virtually reach their health care providers have quickly become a mainstay of medical care during the COVID-19 pandemic. Weill Cornell Medicine’s Center for Virtual Care is positioned at the leading edge of this health care delivery transformation. Leveraging their years of experience with video visits, the center’s experts train providers how to best use it to give their patients comprehensive, compassionate care.

Since its formal launch in early 2020, the center has hosted 30 sessions with more than 500 health care providers across the continuum – physicians, residents, medical students, physician assistants and physician assistant students, nurses, care managers and other practitioners – teaching them “web-side” manner, how to examine patients and make treatment-related decisions remotely, and other fundamentals through live courses and simulations. Trainings began in person, but quickly transitioned to remote learning in March 2020 with the emergence of COVID-19. The center’s latest offering is a two-week online course, developed in collaboration with eCornell, that provides strategies practitioners can use when meeting remotely with their patients.

“Our physicians have been delivering digital health care since 2016 and have seen firsthand the power of the virtual doctor’s office in reaching our patients, especially with the COVID-19 pandemic,” said Dr. Rahul Sharma, chairman of Weill Cornell Medicine’s Department of Emergency Medicine, which operates the center. “The Center for Virtual Care strives to train our health care colleagues on digital health best practices and drive national dialogue about the value of this new clinical medium in delivering the finest patient care.”

The new eCornell course, which features a curriculum in-line with the Association of American Medical College’s Telehealth Competencies, offers instruction on how to harness the digital health medium to effectively create a therapeutic patient-provider encounter. Students learn essentials including verbal and nonverbal communication strategies to convey empathy and compassion, how to overcome technical challenges, and how to conduct remote patient exams.

“As physicians, providing high-quality care is the bedrock of our work, regardless of whether that care happens in-person or on a screen,” said Dr. Peter Greenwald, director of telemedicine in the Department of Emergency Medicine and an assistant professor of clinical emergency medicine at Weill Cornell Medicine. “The work we are doing at the Center for Virtual Care is helping establish a new patient provider space that, like the office exam room, has its own set of rules, practices and tools of the trade. The material we teach at the center allows practitioners to become proficient in this new space in order to make their digital health care a practice of excellence.”

The digital medium offers patients the opportunity to connect with providers at a time and place that’s convenient for them. But telemedicine practice can create new communication barriers and may even expose providers and institutions to risk. The Center for Virtual Care tackles these issues to ensure that digital health offers its very best therapeutic benefits at the lowest medical-legal risk.

“The center’s goal is to empower physicians and provide them with the tools they need to become proficient in the digital space,” said Dr. Neel Naik, the director of simulation education for the Department of Emergency Medicine and an assistant professor of clinical emergency medicine at Weill Cornell Medicine. “The pandemic has accelerated a shift toward virtual patient encounters and has underscored just how important these skills are in fostering a positive health care experience.”

Megan Burke is chief marketing officer for eCornell and Alyssa Sunkin-Strube is newsroom manager for Weill Cornell Medicine.

  0  

New eCornell program offers wellness counseling skills

Wellness – defined by the World Health Organization as “a state of complete physical, mental and social well-being” – is essential not only in the health care industry but in every profession and everyday life. However, creating a culture or achieving an optimal state of well-being can be challenging.

To better equip helping professionals, the Cornell Institute for Healthy Futures (CIHF) has developed a Wellness Counseling certificate program, offered through eCornell. Ideal for any human resource or wellness professional, this program offers best-in-practice, demonstrated counseling techniques and steps for achieving and creating a culture of wellness.

“Whatever industry a helping professional is in, the ability to effectively lead and curate a culture of wellness is integral,” said program author Beth McKinney, lecturer in nutritional sciences in the College of Human Ecology and CIHF faculty fellow. “This program develops those skills, enabling professionals with the tools to create rapport, elicit behavior change, have open and empathetic communication and enhance their overall effectiveness.”

This program consists of four two-week classes:

  • Understanding the Person;
  • Understanding the Deeper Need;
  • Eliciting New Behaviors; and
  • Promoting Organizational Wellness.

Upon completion, participants will receive a certificate from the College of Human Ecology and 40 professional development hours.

For more information, visit the eCornell website.

  0  

This holiday season, give the gift that keeps on giving

Looking for a great gift idea? Consider giving a gift that will stand the test of time.

The Wine Lover
This holiday season, focus on something everyone can agree on—wine. If you love wine and want to take your appreciation to the next level, you’ll benefit from this hands-on course offered by Cornell University. Take a journey through the winemaking process from grape to glass, learning how to taste and evaluate wine with guidance from world-renowned Cornell hospitality experts. Learn more

 

The Beer Enthusiast
With so many beer options out there, how will you decide? It’s a question restaurants and enthusiasts alike are asking. Discover the answer with the Beer Appreciation certificate program at Cornell! This program provides an end-to-end understanding of beer production, tasting, and selection for making educated decisions on your choice beverage. From ingredients and process to sensory analysis, you will expand your knowledge and appreciation of beers.

 

The Entrepreneur
Have a great idea? Master the skills needed to get it off the ground with Cornell’s new Entrepreneurship certificate program. Designed for both entrepreneurs and new investors, this program guides you from assessing your concept’s viability, to navigating the pitch process, securing the right kind of funding and maintaining key relationships. Don’t wait; turn your side hustle into your main gig!

 

The Techie
Python is one of today’s fastest-growing and in-demand programming languages. The Software Development in Python certificate program follows a rigorous, real-world approach to developing proficiency in Python programming and software development. Don’t hesitate to add this skill to your resume!

 

The Health Guru
Striving to be the healthiest version of yourself? Earn a Nutrition and Healthy Living certificate to get an in-depth, contemporary scientific look at nutrition, exercise, weight loss and disease prevention. You’ll come away with a holistic view of how biochemical pathways work together with physiological systems and behavior to determine nutritional health and overall wellness.

 

  0  

Adding It Up: Hidden Lifetime Costs of Sexual Assault and Misconduct

Victims of sexual assault, violence, and misconduct suffer in multiple ways following the crimes committed against them. Liz Karns, professor from Cornell’s ILR School, has been following the lifetime costs for victims of these sexual crimes. As both a lawyer and an epidemiologist, she is tackling the data from an interesting perspective and sat down with eCornell’s Chris Wofford to discuss the lasting effects for survivors both on campus and in the workplace.

What follows is an abridged version of their conversation.

Wofford: You are an epidemiologist and also a lawyer, so you’re coming at this from two very interesting angles that together make for a really compelling story, so tell me a little bit about when you started looking at this and your experience.

Karns: As an epidemiologist, I started thinking about it just in terms of the types of data we would have, right? But it wasn’t until I went to law school like 13 years after being an epidemiologist that I started applying it to sexual assault, and in that context, I treated, and I continue to treat those cases just as I would any type of medical malpractice case or environmental harm case. They are the exact same set of ways that we assess damage. We need the studies, we need the research, we need the experts, and, it’s been a while coming that we got all of those things together. But at this point, we have so much research, so much information that makes it quite clear that the cost is a lifetime cost, and that currently it is usually the person, the victim, who pays for that – and that’s my interest, is to shift that.

In 2015 we had like a banner year of doing lots of different studies, and these studies were all essentially asking the same, which was ‘Have you been sexually assaulted while in college?’ And, there was some slight difference in terms of the phrasing. This was a study that was done by Kaiser and the Washington Post, and we have 25% of people who were assaulted since starting college, 20% for women, 5% for men. We see pretty similar pattern across all the different places, right? It never varies in a big way. The one that says 27 AAU, this was a study that Cornell was part of. We had 27 different colleges that did the same survey, and it’s important to have this information because it’s consistent across studies. There’s so many people who will say, ‘Oh, but people just make that up or it was dependent on the respondents.’ There’s been a lot of reliability and validity testing on this and this is solid data. The sad thing is that this the exact same data that we had in 1987. The numbers are the same since 1987 – roughly 20% is a consistent thing and it has not changed with anything.

Part of the reason that we add this up is that money matters. Somehow when we start attaching a price tag, people become more accountable, and the different systems that we look at are the legal systems. We’ve got the criminal and the civil system, and the financial obligation that arises out of that. Let’s imagine that a perpetrator is found guilty, and under the criminal system, ordered to pay restitution. That means they have to pay the victim money, and that is a contract now. That cannot be discharged, under a personal bankruptcy, so it is something that will stay with that perpetrator forever until they’ve paid it off.

Wofford: Wow.

Karns: That would change the world.

Wofford: I would imagine.

Karns: This is the standard approach to all injuries. This is exactly what’s used in your car accidents, your slip and falls, medical malpractice, everything else, so it’s interesting that people don’t think of it when it comes to sexual assault. So it’s part of my job, to articulate it, and make people think about that. If we assign dollars, we’ll get societal change. I’m quite sure about this one. The person initially talks to the psychiatrist, and then talks about different situations that this arises in, to figure out how invasive it is in their life. I have had people who could not go to covered parking lots ever again in their lives, and that meant that they would drive 50 miles out of the way to go to a different train station because they didn’t wanna use that one that had the covered parking lot. That meant that she couldn’t take certain jobs, so it’s got this sort of ripple effect.

Wofford: Yes, exactly. So what I’m getting at, or where I was going with that was, linking this particular diagnosis to these behaviors, and I wonder often how that plays out legally.

Karns: Yeah, well, I mean it’s absolutely part of the case because you’ve got, first the initial injury, which is the assault itself, and that doesn’t have a huge amount of value, obviously, like in terms of money, but the ways that it impairs one’s life after that are what get documented. That is the job of the lawyer to go through and describe the day and the life – you bring in different experts to say, this person will have a very predictable set of problems when they have their own children, so that’s a cost that you should be thinking about.

So the expert is who ties this person’s diagnosis and situation and then projects it forward, and when I’ve worked on medical malpractice cases where we had something happening to an infant, we would do the same thing. We’d say this is what their life looks like in the future.

Wofford: Yeah. Okay, behavioral health, again, this is not a big surprise, that they are more likely to be using alcohol or hard drugs, and they’re aware that they need to cut down, so they are aware that they’re using it as a substitute for treatment, if you will. And then this is the one that the insurance company knows is that they continually use more healthcare than non-victims, so whenever somebody discusses, gosh, maybe we should decide this is a preexisting condition, you can see why the insurance company is interested in that ’cause these are very costly, they have higher costs, 20% higher.

Karns: So, when people start acknowledging that the assault occurred, and that’s a process in itself, and realizing that they need counseling, it’s not unusual to have a diagnosis come up from that. They don’t have to go and seek a diagnosis to say, ‘mmm, boom, I have it.’ It’s going to evolve, and you have this statute of limitations, so you have so many years afterwards, that depends on your state, to file this case, and so, you don’t have to seek it right away. If you’re gonna build a case, and you’re talking to your lawyer, right, a lawyer, then they will very much ask you, ‘Are you in counseling? Do you have a diagnosis?’ Most of us have health insurance that would cover some aspect of that so there’s some record of that as well.

Wofford: So you’re recommending that the damages are then directed to the perpetrator, legally. What is the state of the law, what’s happening out there, as far as cases like this? Is this line of thinking adapted?

Karns: Yeah.

Wofford: Okay, so this is nothing new.

Karns: This is not, nothing I’m doing is new. All I’m doing is calling attention to it in a different way, and the way that I check myself, if you will, is that I look at what are called default cases – these are cases where the perpetrator, who then became a defendant in civil court, never showed up and the plaintiff, the person who experienced the assault, has the right to make the argument of, ‘What are the costs?’ And then the judge assesses those costs and decides whether or not they’re warranted.

This is all about true economic loss.

But, compensation funds will actually pay for things like therapy, so you could get that immediate counseling that you need, it’s just onerous to get there. Second one is – I mentioned this before – criminal restitution. This is part of any court process, that the criminal court can order the perpetrator to pay the victim. And then finally, civil damages, and this is the one I think most of us are familiar with, where we undertake legal action. The plaintiff, the person who is the victim, brings the case against that defendant, and everything I’ve talked to today goes into that damages number, and then that number gets used all the way through the civil court process, so demand letter, complaint, arguments.

So shifting the burden is what we need to do. That is absolutely what we’ll have to do. So things we can change. One, sexual assault happens in schools quite a lot, and we need to address the fact that it interrupts their education, and we need to think about a student loan deferral on this. It’s absolutely mandatory. The legal ones, holding the perpetrators responsible. And then finally, support, engaging survivors in discussions about the economic impact.

Want to hear more? Watch an excerpt of the live eCornell WebSeries event, Adding It Up: Hidden Lifetime Costs of Sexual Assault and Misconduct, and subscribe to future events.

  0  

New Certificate Program Teaches Dietitians Skills to Elicit Change

Cornell University’s director of wellness, Beth McKinney, has developed an online certificate program for registered dietitian nutritionists. The Nutrition Counseling certificate provides RDNs with client-directed counseling techniques they can use to elicit clients’ best thinking and results. Each course in the program provides six Continuing Professional Education (CPE) units for a total of 24 CPEs.

McKinney, a certified health education specialist and RDN who teaches an undergraduate course called Nutrition Communications and Counseling to upper level dietetics majors, has distilled her experience, and social cognitive learning theory, into an online program that allows RDNs to systematically learn, practice and hone their counseling skills.

“There’s a gap between the nutrition knowledge we learn in school and our ability to help clients make real changes. Even if most RDNs learned client-directed counseling, many haven’t had sufficient opportunities to practice it. These courses provide not only the techniques to transform behavior, but also videos in which practitioners can see counseling in action,” said McKinney, MSEd, RDN, CHES.

The Nutrition Counseling certificate, offered through eCornell, is comprised of four online courses that can be completed in three to five hours per week:

  • Getting into the client-directed counseling mindset with tools to develop self-awareness.
  • Mastering new, empathic ways to respond to clients that elicit more information and uncover problems from their perspective.
  • Motivational goal setting techniques that bring out clients’ best thinking.
  • Translating nutrition information to diverse clientele, using your authentic voice.

The program is open only to RDNs in the U.S. Students who complete all courses receive a Nutrition Counseling certificate from Cornell’s Division of Nutritional Sciences.